BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 21.089
EU - Europa 8.401
AS - Asia 3.771
AF - Africa 29
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 19
Totale 33.357
Nazione #
US - Stati Uniti d'America 21.050
CN - Cina 2.539
UA - Ucraina 2.374
DE - Germania 1.859
HK - Hong Kong 926
IT - Italia 897
PL - Polonia 802
GB - Regno Unito 647
FI - Finlandia 556
IE - Irlanda 423
FR - Francia 358
RU - Federazione Russa 242
IN - India 131
BE - Belgio 95
SE - Svezia 88
SG - Singapore 41
CA - Canada 34
TR - Turchia 34
VN - Vietnam 33
AU - Australia 26
NL - Olanda 26
EU - Europa 22
IR - Iran 18
MU - Mauritius 17
BR - Brasile 13
ES - Italia 12
KR - Corea 9
JP - Giappone 7
TW - Taiwan 6
RO - Romania 5
MA - Marocco 4
SA - Arabia Saudita 4
TH - Thailandia 4
DK - Danimarca 3
KW - Kuwait 3
TN - Tunisia 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
CL - Cile 2
EE - Estonia 2
LV - Lettonia 2
MN - Mongolia 2
MX - Messico 2
MY - Malesia 2
RS - Serbia 2
SL - Sierra Leone 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 33.357
Città #
Fairfield 3.707
Woodbridge 2.816
Houston 1.875
Jacksonville 1.768
Ashburn 1.620
Seattle 1.438
Cambridge 1.344
Ann Arbor 1.321
Wilmington 1.236
Hong Kong 922
Warsaw 801
Princeton 786
Nanjing 639
Chandler 626
Dublin 423
New York 399
Beijing 328
Dearborn 325
Helsinki 305
Nanchang 247
Brescia 210
Des Moines 175
Shenyang 174
San Diego 169
Changsha 152
Milan 145
Hebei 135
Jinan 119
Jiaxing 96
Shanghai 90
Tianjin 90
Brussels 88
Lancaster 87
Kunming 79
London 71
Hangzhou 51
Ningbo 50
Norwalk 48
San Mateo 45
Verona 45
Nürnberg 42
Zhengzhou 41
Taizhou 36
San Francisco 34
Augusta 30
Dong Ket 30
Guangzhou 30
Lanzhou 30
Toronto 26
Rome 25
Haikou 23
Leawood 22
Kilburn 21
Orange 20
Kocaeli 19
Boardman 18
Fuzhou 18
Taiyuan 18
Hefei 16
Frankfurt am Main 15
Mumbai 15
Lappeenranta 14
Ardabil 13
Chiswick 13
Monmouth Junction 13
Torino 13
Changchun 12
Redwood City 12
Hounslow 10
Pune 10
Washington 10
Catania 9
Chicago 9
Gunzenhausen 9
Prescot 8
São Paulo 8
Acton 7
Bergamo 7
Falkenstein 7
Melbourne 7
Phoenix 7
Sydney 7
Trieste 7
Wandsworth 7
Bologna 6
Cingia de' Botti 6
Los Angeles 6
Lucca 6
New Bedfont 6
San Jose 6
Taipei 6
Canberra 5
Castelli Calepio 5
Dallas 5
Honolulu 5
La Loggia 5
Mantova 5
Redmond 5
Rende 5
San Giuliano Terme 5
Totale 25.880
Nome #
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 227
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 200
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 200
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 199
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 197
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 188
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 183
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 178
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 169
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 167
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 158
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 154
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 153
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 150
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 150
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 150
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 149
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 148
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 147
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 147
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 144
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 143
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 140
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 140
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 140
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 140
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 140
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 138
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 138
COVID-19 impact on consecutive neurological patients admitted to the emergency department 138
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 137
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 136
A complicated case of intracranial hypotension: Diagnostic and management strategies 136
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 131
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 130
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 127
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 126
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 123
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 122
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 122
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 121
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 121
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 119
Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates 116
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 116
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 116
Autoimmunity and frontotemporal dementia 116
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 116
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 115
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 115
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 115
Advances on biological markers in early diagnosis of Alzheimer disease 115
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 114
A case report: doctor, my daughter has Alzheimer's disease. 112
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 112
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 112
Action and object naming in Parkinson's disease without dementia. 111
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 111
Vascular risk factors and cognition in Parkinson's disease 111
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 110
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. 109
Association between tau H2 haplotype and age at onset in frontotemporal dementia 109
A complicated case of intracranial hypotension: diagnostic and management strategies. 109
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 109
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 109
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 108
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 108
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 108
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 108
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. 107
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 106
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. 106
Three sisters covering the transient global amnesia spectrum 105
Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders 105
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 105
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. 105
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 105
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 104
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 104
Pattern ofbehavioral disturbances in corticobasal degeneration syndrome and progressivesupranuclear palsy 104
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 103
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 102
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 102
The Neuroimaging Signature of Frontotemporal Lobar Degeneration Associated with Granulin Mutations: An Effective Connectivity Study 102
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 102
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 102
Anodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal Syndrome. 102
C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. 102
White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations. 102
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 101
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. 101
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 101
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 100
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 100
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 100
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. 100
Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. 99
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 99
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 99
Heterozygous TREM2 mutations in frontotemporal dementia 99
Totale 12.550
Categoria #
all - tutte 151.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.871 0 0 0 0 0 0 0 0 0 591 1.185 1.095
2019/202010.766 1.516 468 458 1.341 715 1.237 1.091 1.193 829 1.071 309 538
2020/20216.319 181 845 254 695 343 680 245 720 784 617 698 257
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20242.545 169 72 289 209 107 499 111 117 950 22 0 0
Totale 34.058